85 related articles for article (PubMed ID: 1987497)
21. Anorectal malignant melanoma. A clinicopathologic study, including immunohistochemistry and DNA flow cytometry.
Ben-Izhak O; Levy R; Weill S; Groisman G; Cohen H; Stajerman S; Misselevich I; Nitecky S; Eidelman S; Kerner H
Cancer; 1997 Jan; 79(1):18-25. PubMed ID: 8988722
[TBL] [Abstract][Full Text] [Related]
22. DNA ploidy-characteristics of human malignant melanoma analysed by flow cytometry and compared with histology and clinical course.
Søndergaard K; Larsen JK; Møller U; Christensen IJ; Hou-Jensen K
Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 42(1):43-52. PubMed ID: 6132488
[TBL] [Abstract][Full Text] [Related]
23. Flow cytofluorometric DNA analyses of metastases of human malignant melanomas.
Hansson J; Tribukait B; Lewensohn R; Ringborg U
Anal Quant Cytol; 1982 Jun; 4(2):99-104. PubMed ID: 7114625
[TBL] [Abstract][Full Text] [Related]
24. Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors.
Van den Berg E; Van Oven MW; de Jong B; Dam A; Wiersema J; Dijkhuizen T; Hoekstra HJ; Molenaar WM
Lab Invest; 1994 Mar; 70(3):307-13. PubMed ID: 8145525
[TBL] [Abstract][Full Text] [Related]
25. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome.
Demirel D; Laucirica R; Fishman A; Owens RG; Grey MM; Kaplan AL; Ramzy I
Cancer; 1996 Apr; 77(8):1494-500. PubMed ID: 8608534
[TBL] [Abstract][Full Text] [Related]
26. Differential pattern of DNA-aneuploidy in human malignancies.
Büchner T; Hiddemann W; Wörmann B; Kleinemeier B; Schumann J; Göhde W; Ritter J; Müller KM; von Bassewitz DB; Roessner A
Pathol Res Pract; 1985 Jan; 179(3):310-7. PubMed ID: 3856834
[TBL] [Abstract][Full Text] [Related]
27. Single cell DNA cytophotometry in clinical stage I malignant melanoma. Relationship to prognosis.
Lindholm C; Hofer PA; Jonsson H
Acta Oncol; 1990; 29(2):147-50. PubMed ID: 2334568
[TBL] [Abstract][Full Text] [Related]
28. [Flow cytometric analysis of DNA from 98 cases of soft tissue tumors and its clinical significance].
Li S
Zhonghua Wai Ke Za Zhi; 1990 May; 28(5):281-4, 318. PubMed ID: 2086097
[TBL] [Abstract][Full Text] [Related]
29. Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.
De Lena M; Barletta A; Marzullo F; Lorusso V; Berardi F; Tommasi S; Mangia A; Paradiso A
Haematologica; 1992; 77(1):84-6. PubMed ID: 1398287
[TBL] [Abstract][Full Text] [Related]
30. The clinical relevance of ploidy and S-phase fraction determination in salivary gland tumors: a flow cytometric study of 97 cases.
Pinto AE; Fonseca I; Soares J
Cancer; 1999 Jan; 85(2):273-81. PubMed ID: 10023692
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic factors in neuroblastoma. Usefulness of DNA analysis using flow cytometry on paraffin-embedded material].
Massara FM; Tonello M; Forni M; Fruttero A; Lantermo R; Pugno F; Cordero di Montezemolo L; Ruà S
Pediatr Med Chir; 1996; 18(2):141-8. PubMed ID: 8767575
[TBL] [Abstract][Full Text] [Related]
32. DNA ploidy in malignant melanoma, skin cancer and pigmented nevi.
Skowronek J; Adamska K; Filipiak K; Karaś Z; Krenz RM; Rutkowski R; Warchoł JB
Neoplasma; 1997; 44(5):282-8. PubMed ID: 9473786
[TBL] [Abstract][Full Text] [Related]
33. The role of DNA flow cytometry in borderline malignant ovarian tumors.
Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM
Cancer; 1996 Aug; 78(4):794-802. PubMed ID: 8756374
[TBL] [Abstract][Full Text] [Related]
34. Malignant melanoma: analysis by DNA flow cytometry.
Wass J; Zbroja RA; Young GA; Vincent PC; Joyce RM; Croaker G
Pathology; 1985 Jul; 17(3):475-80. PubMed ID: 4069767
[TBL] [Abstract][Full Text] [Related]
35. Flow and image cytometric DNA analysis in rhabdomyosarcoma.
Kowal-Vern A; Gonzalez-Crussi F; Turner J; Trujillo YP; Chou P; Herman C; Castelli M; Walloch J
Cancer Res; 1990 Sep; 50(18):6023-7. PubMed ID: 2393866
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of DNA cytometry in comparison with histologic measurements in malignant melanomas.
Vogt T; Stolz W; Hohenleutner U; Schiffner R; Landthaler M
Recent Results Cancer Res; 1995; 139():195-204. PubMed ID: 7597290
[TBL] [Abstract][Full Text] [Related]
37. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
38. Significance of aneuploid stemlines in testicular nonseminomatous germ cell tumors.
de Graaff WE; Sleijfer DT; de Jong B; Dam A; Schraffordt Koops H; Oosterhuis JW
Cancer; 1993 Aug; 72(4):1300-4. PubMed ID: 8393372
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of DNA aneuploidy in diffuse malignant mesothelioma.
Isobe H; Sridhar KS; Doria R; Cohen F; Raub WA; Saldana M; Krishan A
Cytometry; 1995 Jan; 19(1):86-91. PubMed ID: 7705189
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of DNA flow cytometry in sympathoadrenal paragangliomas.
García-Escudero A; de Miguel-Rodríguez M; Moreno-Fernández A; Navarro-Bustos G; Galera-Ruiz H; Galera-Davidson H
Anal Quant Cytol Histol; 2001 Jun; 23(3):238-44. PubMed ID: 11444194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
